AAAAAA

   
Results: 1-15 |
Results: 15
Analysis of CD34(+) cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34(+) cell dose,but steady state levels do not correlate with bone marrow reserve
Authors: Pratt, G Rawstron, AC English, AE Johnson, RJ Jack, AS Morgan, GJ Smith, GM
Citation: G. Pratt et al., Analysis of CD34(+) cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34(+) cell dose,but steady state levels do not correlate with bone marrow reserve, BR J HAEM, 114(4), 2001, pp. 937-943
In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression
Authors: Rawstron, AC Barrans, SL Blythe, D English, A Richards, SJ Fenton, JAL Davies, FE Child, JA Jack, AS Morgan, GJ
Citation: Ac. Rawstron et al., In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression, BR J HAEM, 113(3), 2001, pp. 794-802
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma
Authors: Davies, FE Forsyth, PD Rawstron, AC Owen, RG Pratt, G Evans, PAS Richards, SJ Drayson, M Smith, GM Selby, PJ Child, JA Morgan, GJ
Citation: Fe. Davies et al., The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma, BR J HAEM, 112(3), 2001, pp. 814-819
Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myeloma
Authors: Pratt, G Fenton, JAL Davies, FE Rawstron, AC Richards, SJ Collins, JE Owen, RG Jack, AS Smith, GM Morgan, GJ
Citation: G. Pratt et al., Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myeloma, BR J HAEM, 112(2), 2001, pp. 388-391
Interleukin 6, tumour necrosis factor alpha and lymphotoxin polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma
Authors: Dring, AM Davies, FE Rollinson, SJ Roddam, PL Rawstron, AC Child, JA Jack, AS Morgan, GJ
Citation: Am. Dring et al., Interleukin 6, tumour necrosis factor alpha and lymphotoxin polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma, BR J HAEM, 112(1), 2001, pp. 249-250
Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome andcan be used to optimize therapy
Authors: Rawstron, AC Kennedy, B Evans, PAS Davies, FE Richards, SJ Haynes, AP Russell, NH Hale, G Morgan, GJ Jack, AS Hillmen, P
Citation: Ac. Rawstron et al., Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome andcan be used to optimize therapy, BLOOD, 98(1), 2001, pp. 29-35
High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment
Authors: Davies, FE Rollinson, SJ Rawstron, AC Roman, E Richards, S Drayson, M Child, JA Morgan, GJ
Citation: Fe. Davies et al., High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment, J CL ONCOL, 18(15), 2000, pp. 2843-2851
Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests
Authors: Davies, FE Rawstron, AC Pratt, G Coupe, R Clarke, D Lubenko, A Short, K Perren, TJ Selby, PJ MacLennan, S Major, K Woodhead, V Robinson, F Child, JA Smith, GM Johnson, PWM Morgan, GJ
Citation: Fe. Davies et al., Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests, HEMATOL ONC, 18(3), 2000, pp. 111-120
Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria
Authors: Richards, SJ Rawstron, AC Hillmen, P
Citation: Sj. Richards et al., Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria, CYTOMETRY, 42(4), 2000, pp. 223-233
Controversies surrounding the clonogenic origin of multiple myeloma
Authors: Davies, FE Rawstron, AC Owen, RG Morgan, GJ
Citation: Fe. Davies et al., Controversies surrounding the clonogenic origin of multiple myeloma, BR J HAEM, 110(1), 2000, pp. 240-241
The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells
Authors: Rawstron, AC Fenton, JAL Ashcroft, J English, A Jones, RA Richards, SJ Pratt, G Owen, R Davies, FE Child, JA Jack, AS Morgan, G
Citation: Ac. Rawstron et al., The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells, BLOOD, 96(12), 2000, pp. 3880-3886
The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment
Authors: Rawstron, AC Rollinson, SJ Richards, S Short, MA English, A Morgan, GJ Hale, G Hillmen, P
Citation: Ac. Rawstron et al., The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment, BR J HAEM, 107(1), 1999, pp. 148-153
FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells
Authors: Davies, FE Rawstron, AC Pratt, G O'Connor, S Su'ut, L Blythe, D Fenton, J Claydon, D Child, JA Jack, AS Morgan, GJ
Citation: Fe. Davies et al., FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells, BR J HAEM, 106(1), 1999, pp. 40-46
Liposomal daunorubicin: In vitro and in vivo efficacy in multiple myeloma
Authors: Pratt, G Wiles, ME Rawstron, AC Davies, FE Fenton, JAL Proffitt, JA Child, JA Smith, GM Morgan, GJ
Citation: G. Pratt et al., Liposomal daunorubicin: In vitro and in vivo efficacy in multiple myeloma, HEMATOL ONC, 16(2), 1998, pp. 47-55
True spectrum of 14q32 translocations in multiple myeloma
Authors: Pratt, G Fenton, JAL Proffitt, JA Rawstron, AC Davies, FE Child, JA Morgan, GJ
Citation: G. Pratt et al., True spectrum of 14q32 translocations in multiple myeloma, BR J HAEM, 103(4), 1998, pp. 1209-1210
Risultati: 1-15 |